Thoracic Cancer Q2 Unclaimed
Thoracic Cancer is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 55. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1800 €. The scope of the journal is focused on treatment and research, Asia-Pacific, thoracic cancer, prevention. It has an SJR impact factor of 0,795 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,795.
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1800 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,795
SJR Impact factor55
H Index286
Total Docs (Last Year)1311
Total Docs (3 years)8484
Total Refs3250
Total Cites (3 years)1262
Citable Docs (3 years)2.41
Cites/Doc (2 years)29.66
Ref/DocOther journals with similar parameters
Clinical and Translational Oncology Q2
Neuro-Oncology Practice Q2
Revista de Saude Publica Q2
Human Vaccines and Immunotherapeutics Q2
British Journal of Nutrition Q2
Compare this journals
Aims and Scope
Best articles by citations
Validation of the Mandarin Chinese version of the Leicester Cough Questionnaire in non-small cell lung cancer patients after surgery
View moreSpontaneous regression of non-small cell lung cancer that progressed after multiple chemotherapies: A case report
View moreMetastases of basal-like breast invasive ductal carcinoma to the endometrium: A case report and review of the literature
View moreRapidly growing pleural liposarcoma masquerading as extrapleural hematoma
View moreSubsternal hand-assisted videothoracoscopic lung metastasectomy: Long term results in a selected patient cohort
View moreClinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis
View moreSolitary pulmonary metastasis from malignant melanoma of the bulbar conjunctiva presenting as a pulmonary ground glass nodule: Report of a case
View moreMetastasis in the subcarinal lymph node with unknown primary tumor
View moreClinical experiences with molecular targeted therapy in lung cancer in China
View moreDownregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy
View moreMixed-type primary germ cell tumor of the mediastinum in a young adult male with a sudden life threatening condition: A case report
View morePrognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC
View moreOvercoming T790M mutant small cell lung cancer with the third-generation EGFR-TKI osimertinib
View moreCharacterization of solitary pulmonary nodules using double phase Tc-99m methoxyisobutylisonitrile scan: Comparison of visual and quantitative analyses
View moreManagement of post-pneumonectomy syndrome using tissue expanders
View moreHuman leukocyte antigen(HLA)-Ggene polymorphism in patients with non-small cell lung cancer
View morePreferred surgical procedure for posterior mediastinal neurogenic tumor
View morePrognostic impact of examined lymph node count in pT1N0M0 esophageal cancer: A population-based study
View moreCirculating plasma lncRNAs as novel markers of
View moreMechanism research of miR-34a regulates Axl in non-small-cell lung cancer with gefitinib-acquired resistance
View moreManagement of immune checkpoint inhibitor-related rheumatic adverse events
View morePrevalence of low body mass index among newly diagnosed lung cancer patients in North India and its association with smoking status
View moreMultiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD-L1 immunohistochemistry for predicting response to anti-PD-1/PD-L1 immunotherapy
View moreA randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer
View more
Comments